Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with genetically defined diseases.
Stock is 

SEC Filing Details

Document Details

Form
Filing Date
Aug 5, 2021
Document Date
Aug 1, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Agios Pharmaceuticals, Inc.
Issuer
AGIOS PHARMACEUTICALS, INC.
Filer
WASHBURN THEODORE JAMES JR.